| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER, Director | C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK | /s/ Adam C. Vandervoort, Attorney-in-Fact | 12 Mar 2026 | 0001347535 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDOC | Common Stock | Options Exercise | +39,160 | +12% | 367,022 | 10 Mar 2026 | Direct | F1 | ||
| transaction | TDOC | Common Stock | Options Exercise | +25,493 | +6.9% | 392,515 | 10 Mar 2026 | Direct | F2 | ||
| transaction | TDOC | Common Stock | Sale | $152,243 | -27,731 | -7.1% | $5.49 | 364,784 | 11 Mar 2026 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDOC | Restricted Stock Units | Options Exercise | -39,160 | -17% | $0.000000* | 195,803 | 10 Mar 2026 | Common Stock | 39,160 | Direct | F1, F4 | ||
| transaction | TDOC | Performance Stock Units | Award | +43,703 | $0.000000* | 43,703 | 10 Mar 2026 | Common Stock | 43,703 | Direct | F5, F6, F7 | |||
| transaction | TDOC | Performance Stock Units | Options Exercise | -25,493 | -58% | $0.000000* | 18,210 | 10 Mar 2026 | Common Stock | 25,493 | Direct | F2, F8 |
| Id | Content |
|---|---|
| F1 | Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| F2 | Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| F3 | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| F4 | On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| F5 | Each performance stock unit represents a contingent right to receive one share of TDOC common stock. |
| F6 | Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. |
| F7 | The performance stock units vest as to seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. |
| F8 | On March 10, 2026, the reporting person earned 43,703 performance stock units, vesting seven-twelfths on March 10, 2026, with the remainder vesting in five substantially equal quarterly installments over the subsequent 15 months. |